Table 1.
Baseline Characteristics of the Study Sample
| Characteristics | Value (N=6196) |
|---|---|
| Age, y | 71.8±10.4 |
| Female sex, N (%) | 2460 (39.7) |
| Body mass index, kg/m2 | 27.9±5.0 |
| Systolic blood pressure, mm Hg | 131.5±16.5 |
| Hypertension, N (%) | 4514 (73.3) |
| Ever smoking, N (%) | 2331 (39.7) |
| Alcohol abuse, N (%) | 157 (2.6) |
| Diabetes mellitus, N (%) | 1368 (22.3) |
| Dyslipidemia, N (%) | 2697 (44.5) |
| History of myocardial infarction, N (%) | 663 (10.7) |
| Heart failure, N (%) | 1723 (28.6) |
| History of ischemic stroke/TIA/other ischemic‐thromboembolic event, N (%) | 924 (15.1) |
| EHRA score ≥2, N (%) | 5695 (91.9) |
| History of cardioversion and/or ablation, N (%) | 2147 (34.7) |
| Interventions during 1 y, N (%) | |
| Cardioversion | 701 (11.3) |
| Catheter‐based ablation | 226 (3.4) |
| Outcomes over 1 y, N (%) | |
| Stroke/TIA/arterial thromboembolic events | 136 (2.2) |
| Coronary events | 140 (2.3) |
| Heart failure | 155 (2.5) |
| Major bleeding | 168 (2.7) |
| Sinus rhythm | 2022 (32.6) |
| Adequate heart rate | 2734 (44.1) |
Data are presented as mean±SD for continuous variables and number (percentage) for discrete variables. In some patients, different variables were missing, as seen from the numbers. EHRA indicates European Heart Rhythm Association; TIA, transient ischemic attack.